Weaker Buy Today ADMS ranks #567 as BUY CANDIDATE #567 Stronger Buy

ADMS stock forecast Adamas Pharmaceuticals

ADMS stock forecast

Friday December 13, 2019 Change 2.54% Price $6.66
Your prediction: Prediction: Request
VOLUME
Buy
TREND
Buy
MV LONG
Buy

MV SHORT
Buy

PIVOT
Buy

MACD
Sell
Bullish vs. Bearish (1 opinions)
100%
0%
Social Sentiment 0.00

ADMS Forecast and Technical Stock Analysis


Buy candidate since 2019-12-12 Gain 2.54% PDF

Adamas Pharmaceuticals gained 2.54% in the last trading day ( Friday, 13th Dec 2019 ), rising from $6.49 to $6.66 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the day the stock fluctuated 4.95% from a day low at $6.38 to a day high of $6.70. The price has risen in 6 of the last 10 days and is up by 11.85% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 162 870 more shares were traded than the day before. In total, 594 282 shares bought and sold for approximately $3.95 million.

Quick summary:

  • 30 day high of the ADMS stock price was $6.88 and low was $5.19.
  • 90 day high was $7.78 and low was $3.35.
  • 52 week high for Adamas Pharmaceuticals - $12.57 and low - $3.35.
Top Trending Stocks

Trend

Adamas Pharmaceuticals lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 8.17% during the next 3 months and, with 90% probability hold a price between $4.19 and $8.67 at the end of this period.

Top Golden Star Stocks

Signals

Only positive signals in the chart today. Adamas Pharmaceuticals holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $6.51 and $5.42. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday December 11, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSImin/max Values: [ 25 - 75 ]

RSI14 is 75 and the stock is currently not being overbought or oversold

* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.

Support & Resistance

On the downside, the stock finds support just below today's level from accumulated volume at $6.30 and $6.25.

There is natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Adamas Pharmaceuticals finds support just below today's level at $6.30. If this is broken, then the next support from accumulated volume will be at $6.25 and $5.12.

Support: $6.30 Price: $6.66 Resistance: $6.75

Risk

This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.32 between high and low, or 4.95%. For the last week, the stock has had a daily average volatility of 6.00%.

Our recommended stop-loss: $6.36 (-4.44%) (This stock has high daily movements and this gives high risk. There is a buy signal from pivot bottom found 2 days ago.)

6.00 %

Average volatility

Overall risk:

Very Low Low Medium High Very High

Buy Candidate Downgraded

Evaluation

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since last evaluation from a Strong Buy Candidate to a Buy Candidate candidate.

Weaker Buy Today ADMS ranks #567 as BUY CANDIDATE #567 Stronger Buy
Exchange: NASDAQ | NYSE | XLON | AMS | TSX | BRU

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

Proudly made at

ROCKIT